Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt ...

The changes include the renaming of Janssen, the company’s pharmaceutical segment, as Johnson & Johnson Innovative Medicine, while the brand will continue to incorporate the medical technology ...

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.4% year on year to $21.89 billion. The company’s ...